Results 211 to 220 of about 887,943 (333)

Regional, demographic, and temporal trends in myeloid leukemia mortality in the United States (1999-2022): a comprehensive analysis using CDC WONDER. [PDF]

Front Oncol
Lehn J, Fleming H, Billion T, Mirza M.
europepmc   +1 more source

Targeting of the CD161 Inhibitory Receptor Enhances Bone‐Marrow‐Resident Memory CD8+ T‐Cell‐Mediated Immunity against Multiple Myeloma

Advanced Science, EarlyView.
CD161 is identified as a novel inhibitory receptor on bone marrow (BM)‐resident CD8⁺ T cells in multiple myeloma (MM). Through interaction with its ligand CLEC2D, CD161 impairs T‐cell function and promotes immune suppression. Blockade of CD161 restores tissue residency and cytotoxicity of CD8⁺ T cells and enhances chimeric antigen receptor T‐cell (CAR ...
Liwen Wang, Linzhi Xie, Yi Zhou, Shiming Tan, Yan Yu, Qin Zhang, Xuefeng Chen, Yuhan Yan, Ruiheng Luo, Han Xiao, Qian Cheng, Jian Zhang, Ying Li, Erhua Wang, Tiebin Jiang, Jing Liu, Xin Li   +16 more
wiley   +1 more source

Effective treatment of peritoneal myeloid sarcoma with decitabine and venetoclax: A case report. [PDF]

Leuk Res Rep
Sudireddy K, Amin M, Odeh R, Svrcek P, Khedr S, Hutchinson L, Patel SA, Cerny J, Pearson L.   +8 more
europepmc   +1 more source

Harnessing the Biological Responses Induced by Nanomaterials for Enhanced Cancer Therapy

Aggregate, EarlyView.
Nanomaterial (NM)‐induced toxicity can be strategically repurposed for cancer therapy. This review summarizes the mechanism by which NMs selectively activate specific cellular processes to regulate cell fate independently. We also discussed how NMs‐induced biological responses can be leveraged as therapeutic strategies for cancer treatment.
Liting Wang, Hao Fu, Jiangtao Lin, Meng Zhao, Chuanrong Chen, Hongze Liao, Yourong Duan   +6 more
wiley   +1 more source

Blood signals: from birth to disease and death

, 2014
Bowman, T., Flores-Figueroa, E., King, K., Kokkaliaris, K., Lessard, J., Trompouki, E., Will, B.   +6 more
core   +1 more source

A Heart of Myeloid: Extramedullary Chronic Myelomonocytic Leukemia-2 Presenting as a Myeloid Sarcoma of the Pericardium Causing Recurrent Pericardial Effusions. [PDF]

J Med Cases
Frisch A, Boyapati R, Parikh R, Menezes G, Tipirneni N, Ajebo G, Shafer D.   +6 more
europepmc   +1 more source

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia.

Blood, 2017
E. Stein, C. Dinardo, D. Pollyea, A. Fathi, G. Roboz, J. Altman, R. Stone, D. DeAngelo, R. Levine, I. Flinn, H. Kantarjian, R. Collins, M. Patel, A. Frankel, A. Stein, M. Sekeres, R. Swords, B. Medeiros, C. Willekens, P. Vyas, A. Tosolini, Qiang Xu, R. Knight, K. Yen, S. Agresta, S. de Botton, M. Tallman   +26 more
semanticscholar   +1 more source

RETRACTED: El-Garawani et al. <i>In Vitro</i> Induction of Apoptosis in Isolated Acute Myeloid Leukemia Cells: The Role of <i>Anastatica hierochuntica</i> Methanolic Extract. <i>Metabolites</i> 2022, <i>12</i>, 878. [PDF]

Metabolites
El-Garawani IM, Abd El-Gaber AS, Algamdi NA, Saeed A, Zhao C, Khattab OM, AlAjmi MF, Guo Z, Khalifa SAM, El-Seedi HR.   +9 more
europepmc   +1 more source

Male breast cancer following complete remission of acute myeloid leukemia: A case report and literature review. [PDF]

Int J Surg Case Rep
Qiao W, Li P, Chang C, Fan M, Deng M.
europepmc   +1 more source

External Validation of a Multivariable Diagnostic Prediction Model for Acute Invasive Fungal Rhinosinusitis in Tertiary Care Settings

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Prompt detection and intervention are crucial for improving outcomes in acute invasive fungal rhinosinusitis (AIFS). Diagnostic prediction models assist in risk‐stratification, but their accuracy requires testing through external validation.
Aviv Spillinger, Johanna Ellefson, Qiuyu Yang, Linda X. Yin, Janalee K. Stokken, Thomas Pasic, Ian J. Koszewski, Sandra Y. Lin   +7 more
wiley   +1 more source